Disease: Aplastic anemia
- A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia
- A retrospective study of ovarian tissue cryopreservation in female patients with hematological diseases for fertility preservation
- A Review of the Repair of DNA Double Strand Breaks in the Development of Oral Cancer
- A way to "mimic" the pathophysiology of acquired SAA
- Activity and safety of eltrombopag in combination with cyclosporin A as first-line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study
- Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study
- Acute graft versus host disease 1976-2020: reduced incidence and predictive factors
- Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
- Adenocarcinoma with Aplastic Anemia as an Immune-related Adverse Event Caused by Pembrolizumab: Report of a Case
- Advances in nutritional support for children undergoing hematopoietic stem cell transplantation
- Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
- Aplastic Anaemia Associated with Bendamustine Therapy - A Rare Side Effect
- Aplastic anaemia following antibiotic use for urinary tract infection
- Aplastic Anaemia in Pregnancy: A Case-Based Comprehensive Review of the Literature
- Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature
- Aplastic anemia: history and recent developments in diagnosis and treatment
- Bone marrow CD8(+) Trm cells induced by IL-15 and CD16(+) monocytes contribute to HSPC destruction in human severe aplastic anemia
- Characteristic phenotypes of ADH5/ALDH2 deficiency during childhood
- Clinical Signs and Treatment of New-Onset Bone Marrow Failure Associated SARS-CoV-2 Infection in Children: A Single Institution Prospective Cohort Study
- Clonal hematopoiesis in children with predisposing conditions
- Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia
- Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia
- Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine a in children with acquired severe aplastic anemia
- Consideration of ATG-free therapy with eltrombopag and cyclosporine for severe aplastic anaemia
- Deregulated protein homeostasis constrains fetal hematopoietic stem cell pool expansion in Fanconi anemia
- Diagnostic Significance Of Bone Marrow Examination Amongst The Patients With Abnormal Haematological Parameters
- Dioscin alleviates aplastic anemia through regulatory T cells promotion
- Donor-type bone marrow aplasia following hematopoietic stem cell transplantation in a child with a novel <em>SAMD9L</em> variant
- Early differential diagnosis of pancytopenia related diseases based on serum surface-enhanced Raman spectroscopy
- Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis
- Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT
- Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia
- Et barn med langvarig anemi
- Exploration of diagnosis and treatment plans for diffuse panbronchiolitis combined with familial aplastic anemia
- Exploring strategies to optimise outcomes in hepatitis-associated aplastic anaemia patients following haematopoietic stem cell transplantation
- Formononetin reverses Treg/Th17 imbalance in immune-mediated bone marrow failure mice by regulating the PI3K/Akt signaling pathway
- Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience
- Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
- Hematological Indices for Identifying Adverse Outcomes in Children Admitted to Pediatric ICUs
- Hemolysis events in the Phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria
- HERVs may perform as the initial trigger for acquired aplastic anemia
- High rates of intestinal colonization with carbapenemase producing Enterobacteriaceae in hematopoietic stem cell transplant recipients
- HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties
- How to think about the clinical classifications of acquired aplastic anemia
- Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
- Immune thrombocytopenia occurs in an aplastic anemia patient infected with scrub typhus in China
- Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence
- Immunosuppression in two cases of indeterminate hepatitis
- Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation
- Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor
- Inherited bone marrow failure syndromes: phenotype as a tool for early diagnostic suspicion at a major reference center in Mexico
- Insufficient phosphorylation of STAT5 in Tregs inhibits the expression of BLIMP-1 but not IRF4, reduction the proportion of Tregs in pediatric aplastic anemia
- Interleukin-6 and interleukin-8 levels in children with aplastic anemia and its correlation with disease severity and response to immunosuppressive therapy
- Isolation and genomic characterization of chicken infectious anemia virus in Jiangsu province of China during 2020-2022
- Long Term Follow-Up Of Abatacept, Post-Transplantation Cyclophosphamide and Sirolimus (AbaCyS) based Haploidentical Transplantation in Younger Patients with Nonmalignant Diseases
- Low-dose non-steroidal anti-inflammatory drugs: a promising approach for the treatment of symptomatic bone marrow failure in Ghosal hematodiaphyseal dysplasia
- Management of Acute Breakthrough Hemolysis with Intensive Pegcetacoplan Dosing in Patients with PNH
- Mapping aplastic anaemia hospital activity in England
- Mendelian randomization of circulating proteome identifies IFN-gamma as a druggable target in aplastic anemia
- Metagenomic Next-Generation Sequencing (mNGS) of cerebrospinal fluid for diagnosis of human herpesvirus 6B encephalitis following transplantation for severe aplastic anemia
- Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia
- Nomogram establishment for short-term survival prediction in ICU patients with aplastic anemia based on the MIMIC-IV database
- Novel Perspectives on Thrombopoietin Receptor Agonists Applications
- Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
- Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
- Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival
- Pancytopenia with aplastic anemia in systemic lupus erythematosus: case series and literature review
- Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma
- Predictive value of thyroid function in severe aplastic anemia patients treated with immunosuppressive therapy
- Progress in medical therapy in aplastic anemia: why it took so long?
- Pure Red Cell Aplasia Secondary to Parvovirus B19 Infection as a Rare Cause of Anemia in a Dialysis Patient: A Case Report
- Quality of life after immune suppressive therapy in aplastic anemia
- Real-world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria
- Recent advancements in hematopoietic stem cell transplantation in Taiwan
- Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
- Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients following Treatment with Haploid Hematopoietic Stem Cell Transplantation using Modified Post-transplantation Cyclophosphamide
- Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
- Retracted: Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia
- Risk analysis of air pollutants and types of anemia: a UK Biobank prospective cohort study
- Role of miRNAs in T-cell activation and Th17/Treg-cell imbalance in acquired aplastic anemia
- Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials
- Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study
- Sarcopenia in children and adolescents submitted to hematopoietic stem cell transplantation
- Screening and Identification of lncRNA Related to Adipocity of Bone Marrow Microenvironment in Aplastic Anemia
- Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia
- Spurious High Platelet Count without PLT Flag(S) in a Patient with Severe Aplastic Anaemia
- The effect of glucose-6-phosphate dehydrogenase deficiency on allogeneic hematopoietic stem cell transplantation in patients with hematological disorders
- The evolution and impact of sarcopenia in severe aplastic anaemia survivors following allogeneic haematopoietic cell transplantation
- The role of TIM3(+) NK and TIM3(-) NK cells in the immune pathogenesis of severe aplastic anemia
- The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults
- Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey
- To determine the frequency of aldehyde dehydrogenase type 2 (aldh2) deficiency in aplastic anaemia: A single center experience from pakistan
- Transformation of aplastic anemia with paroxysmal nocturnal hemoglobinuria clone to childhood B-cell precursor acute lymphoblastic leukemia
- Transformation of Severe Aplastic Anemia into Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report
- Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using 'Adapted ADAPTE'
- Treatment patterns and outcomes with luspatercept in patients with lower-risk myelodysplastic syndromes: A retrospective US cohort analysis
- Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights
- Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia
- Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series
- When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms